Risk Factors of Thyroid Eye Disease.

作者: Ming Hui Lee , Yip Han Chin , Cheng Han Ng , Kameswara Rishi Yeshayahu Nistala , Zachariah Gene Wing Ow

DOI: 10.1016/J.EPRAC.2020.11.011

关键词:

摘要: Objective To examine risk factors that might be associated with thyroid eye disease (TED) in patients Graves' (GD), which may guide physicians the prevention and management of TED. Methods Medline Embase were searched for articles discussing Comparisons made between GD without TED, active inactive TED patients. Weighted mean differences (WMDs) odds ratios (ORs) determined continuous dichotomous outcomes, respectively. Results pooled random effects using DerSimonian Laird model. Fifty-six included analysis. Smoking, inclusive current previous smoking status, was a significant factor (OR: 2.401; CI: 1.958-2.945; P Conclusion Factors such as smoking, sex, age predispose to A targeted approach is required reduce modifiable smoking.

参考文章(84)
Peter Diem, Bruno MüLLER, Ulrich BüRGI, Mathias Gebauer, Daniel Noth, Graves' ophthalmopathy: natural history and treatment outcomes. Swiss Medical Weekly. ,vol. 131, pp. 603- 609 ,(2001) , 10.4414/SMW.2001.09781
Lakshmi Narasimha Rao, Thiruvelselvan Ponnusamy, Sheena Philip, Rupak Mukhopadhyay, Vijay V. Kakkar, Lakshmi Mundkur, Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob tm2Sgy Ldlr tm1Her/J Mice Lipids. ,vol. 50, pp. 785- 797 ,(2015) , 10.1007/S11745-015-4046-4
Martin N. Gerding, Jolanda W. C. van der Meer, Margreet Broenink, Onno Bakker, Wilmar M. Wiersinga, Mark F. Prummel, Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy Clinical Endocrinology. ,vol. 52, pp. 267- 271 ,(2000) , 10.1046/J.1365-2265.2000.00959.X
Aleksandra Król, Aleksandra Koehler, Mariusz Nowak, Ewa Paliczka-Cieślik, Jolanta Krajewska, Michał Kalemba, Beata Jurecka-Lubieniecka, Kornelia Hasse-Lazar, Barbara Michalik, Sylwia Szpak-Ulczok, Łukasz Zarudzki, Józef Roskosz, Barbara Jarząb, Terapia nadczynności tarczycy jodem promieniotwórczym jest bezpieczna u chorych na chorobę Gravesa i Basedowa z orbitopatią — badanie prospektywne Endokrynologia Polska. ,vol. 65, pp. 40- 45 ,(2014) , 10.5603/EP.2014.0006
Toshi A. Furukawa, Corrado Barbui, Andrea Cipriani, Paolo Brambilla, Norio Watanabe, Imputing missing standard deviations in meta-analyses can provide accurate results Journal of Clinical Epidemiology. ,vol. 59, pp. 7- 10 ,(2006) , 10.1016/J.JCLINEPI.2005.06.006
Jwu Jin Khong, Rebecca F. Goldstein, Kerrie M. Sanders, Hans Schneider, Jeffrey Pope, Kathryn P. Burdon, Jamie E. Craig, Peter R. Ebeling, Serum selenium status in Graves' disease with and without orbitopathy: a case-control study. Clinical Endocrinology. ,vol. 80, pp. 905- 910 ,(2014) , 10.1111/CEN.12392
Brita Winsa, Agneta Mandahl, F Anders Karlsson, Graves' disease, endocrine ophthalmopathy and smoking European Journal of Endocrinology. ,vol. 128, pp. 156- 160 ,(1993) , 10.1530/ACTA.0.1280156
Marlsol Tellez, Jackie Cooper, Charles Edmonds, Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clinical Endocrinology. ,vol. 36, pp. 291- 294 ,(1992) , 10.1111/J.1365-2265.1992.TB01445.X
L. Bartalena, E. Martino, C. Marcocci, F. Bogazzi, M. Panicucci, F. Velluzzi, A. Loviselli, A. Pinchera, More on smoking habits and Graves’ ophthalmopathy Journal of Endocrinological Investigation. ,vol. 12, pp. 733- 737 ,(1989) , 10.1007/BF03350047
Chieh-Chih Tsai, Hui-Chuan Kau, Shu-Ching Kao, Ming-Wei Lin, Wen-Ming Hsu, Jorn-Hon Liu, Yau-Huei Wei, Pulsatile ocular blood flow in patients with Graves' ophthalmopathy. Eye. ,vol. 19, pp. 159- 162 ,(2005) , 10.1038/SJ.EYE.6701434